Core Scientific Faces Proxy Battle as Shareholders Oppose CoreWeave Acquisition
Core Scientific Inc. is facing a proxy battle after two leading proxy advisory firms recommended that shareholders vote against a $9 billion all-stock acquisition offer from CoreWeave, citing concerns over valuation and deal structure.
3 minutes to read



